FlowMAb PE anti-human CD3

Catalog #FM0001-2-PE
Clone:
OKT-3
Reactivities:
Human
As low as $240.00

$240.00 - $350.00

$240.00 - $350.00

Choose an Option...
  • 100 µg - $350.00
  • 25 µg - $240.00
In stock
Only %1 left

Product Details

The OKT-3 monoclonal antibody reacts with human CD3Īµ, a 20 kDa transmembrane cell-surface protein that belongs to the immunoglobulin superfamily. CD3Īµ is one of five polypeptide chains that combine to form the TCR complex. CD3Īµ is expressed on T lymphocytes, NK-T cells, and, to varying degrees, on developing thymocytes. CD3 plays roles in TCR signaling, T lymphocyte activation, and antigen recognition. The OKT3 antibody clone can block the binding of clones SK7 and UCHT1. This R-phycoerythrin (R-PE or PE)-conjugated version of the OKT-3 antibody is useful for flow cytometry.

Specifications

Isotype Mouse IgG2a,Ā Īŗ
Recommended Isotype Control(s) FlowMAb PE mouse IgG2a isotype control, unknown specificity
Conjugation PE
Excitation Source Yellow-Green 488 nm, 532 nm, 561 nm
Excitation Max 496 nm, 566 nm
Emission Max 576 nm
Immunogen Not available or unknown
Reported Applications Flow cytometry
Formulation PBS, pH 7.0
Contains 0.09% Sodium Azide
Production Purified from cell culture supernatant in an animal-free facility
Purification Protein G. Conjugated with R-phycoerythrin under optimal conditions.
Storage The antibody solution should be stored at the stock concentration at 4Ā°C and protected from prolonged exposure to light. Do not freeze.
Flow Cytometry
Willing, A., et al. (2014). "CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis" Eur J Immunol 44(10): 3119-3128. PubMed

Recent findings indicate a pathogenic involvement of IL-17-producing CD8(+) T cells in multiple sclerosis (MS). IL-17 production has been attributed to a subset of CD8(+) T cells that belong to the mucosal-associated invariant T (MAIT) cell population. Here, we report a reduction of CD8(+) MAIT cells in the blood of MS patients compared with healthy individuals, which significantly correlated with IL-18 serum levels in MS patients. In vitro stimulation of peripheral blood mononuclear cells from healthy individuals and MS patients with IL-18 specifically activated CD8(+) MAIT cells. Moreover, IL-18 together with T-cell receptor stimulation induced, specifically on CD8(+) MAIT cells, an upregulation of the integrin very late antigen-4 that is essential for the infiltration of CD8(+) T cells into the CNS. Notably, we were able to identify CD8(+) MAIT cells in MS brain lesions by immunohistochemistry while they were almost absent in the cerebrospinal fluid (CSF). In summary, our findings indicate that an IL-18-driven activation of CD8(+) MAIT cells contributes to their CNS infiltration in MS, in turn leading to reduced CD8(+) MAIT-cell frequencies in the blood. Therefore, CD8(+) MAIT cells seem to play a role in the innate arm of immunopathology in MS.